Breaking News Instant updates and real-time market news.

DXCM

DexCom

$55.72

-1.25 (-2.19%)

16:02
02/27/18
02/27
16:02
02/27/18
16:02

DexCom reports Q4 adjusted EPS 10c, consensus 3c

Reports Q4 revenue $221M, consensus $215.87M. "2017 was defined by several key accomplishments for DexCom, highlighted by record revenue, strong Q4 financial results, and meaningful progress on a number of strategic programs," said Kevin Sayer, President and CEO, DexCom. "In the U.S., our commercial team executed well as we initiated our rollout into the Medicare population, and our International franchise exceeded expectations. DexCom also made big strides with our product pipeline, including our next generation system and with our development partners both in our intensive and non-intensive initiatives. We believe we are well positioned for continued success in 2018."

  • 27

    Feb

  • 05

    Mar

DXCM DexCom
$55.72

-1.25 (-2.19%)

01/30/18
PIPR
01/30/18
NO CHANGE
Target $60
PIPR
Overweight
Study shows superior outcomes for Dexcom over Abbott, says Piper Jaffray
Results of the I HART study that were published in the Diabetic Medicine journal showed superior outcomes for those on the Dexcom's (DXCM) G5 compared to Abbott's (ABT) Libre, Piper Jaffray analyst JP McKim tells investors in a research note. Specifically, G5 reduced time spent in hypoglycaemia both during the day and at night versus Libre that actually increased time, McKim adds. The analyst believes that while patients in the trial were ideal Dexcom candidates given their increased risk of hypoglycemia, the data can be used to differentiate the technology in the eyes of payers. He believes both G5 and Libre have a place in the system for different patient populations. The analyst keeps an Overweight rating on Dexcom with a $60 price target.
02/12/18
OPCO
02/12/18
NO CHANGE
Target $67
OPCO
Outperform
Dexcom price target lowered to $67 from $72 at Oppenheimer
Oppenheimer analyst Steven Lichtman lowered his price target for Dexcom (DXCM) to $67 from $72 on lowered estimates, while reiterating an Outperform rating on the stock. The analyst recently surveyed high-volume U.S. endocrinologists on the latest in continuous glucose monitoring now with Abbott's (ABT) Libre Flash on the market. According to respondents, there is some impact on Dexcom new prescriptions since Libre launch and some current Dexcom patients are interested in switching, but the impact looks within expectations, he contends. Overall, Lichtman believes the rollouts of Libre and Medtronic's (MDT) 670G remain overhangs on Dexcom near-term, but his survey suggests an environment no worse than guidance and conditions on the ground should change again in 2H18 with approval of Dexcom's next-generation G6.
02/26/18
PIPR
02/26/18
NO CHANGE
Target $60
PIPR
Overweight
Medtronic news incremental negative for Dexcom, says Piper Jaffray
Medtronic (MDT) this morning announced it received a new arm indication for its Guardian Sensor 3 which improves the accuracy of the sensor to an 8.7% MARD, likely leading to a non-adjunctive claim for standalone, Piper Jaffray analyst JP McKim tells investors in a research note. The news is an incremental negative for Dexcom (DXCM) shares as a path to non-adjunctive claim for Medtronic has become much clearer, McKim contends. He expects a stand-alone launch of Guardian Sensor 3 sometime in 2018. The analyst believes Dexcom carries more negative headline risk in the near term, but he expects the company to remain the market leader in continuous glucose monitors. As such, McKim thinks longer term investors should be buying the stock. He keeps an Overweight rating on Dexcom with a $60 price target. The stock in morning trading is down 12c to $56.24.
02/27/18
JPMS
02/27/18
NO CHANGE
JPMS
Abbott's strong Libre launch supports cautious Dexcom stance, says JPMorgan
Abbott's Libre launch is off to a strong start in the U.S. with more than 25,000 patients having started on the device since the launch in early December, JPMorgan analyst Michael Weinstein tells investors in a research note. It remains way too early, however, to say what percent of patients will stick with the device, the analyst adds. The Libre launch reinforces the analyst's cautious stance on shares of Dexcom (DXCM). He expects Dexcom's growth to slow over the course of the year and for 2019 to prove "much more challenging" than 2018. Weinstein has an Overweight rating on Abbott and Neutral rating on Dexcom.

TODAY'S FREE FLY STORIES

PENN

Penn National

$35.05

-0.65 (-1.82%)

14:05
07/18/18
07/18
14:05
07/18/18
14:05
Options
Penn National call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$280.81

0.39 (0.14%)

14:02
07/18/18
07/18
14:02
07/18/18
14:02
General news
Employment continued to rise at 'modest to moderate pace,' Fed says »

The Federal Reserve said…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$280.81

0.39 (0.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$280.81

0.39 (0.14%)

14:01
07/18/18
07/18
14:01
07/18/18
14:01
General news
Fed says economic activity continued to expand across the U.S. »

The Federal Reserve said…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$280.81

0.39 (0.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOG

Alphabet

$1,200.65

1.84 (0.15%)

, GOOGL

Alphabet Class A

$1,218.02

4.37 (0.36%)

14:00
07/18/18
07/18
14:00
07/18/18
14:00
Hot Stocks
Alphabet to take Q2 charge of $5.07B for European Commission fine »

Alphabet in a press…

GOOG

Alphabet

$1,200.65

1.84 (0.15%)

GOOGL

Alphabet Class A

$1,218.02

4.37 (0.36%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

  • 23

    Jul

  • 08

    Aug

  • 18

    Sep

  • 28

    Oct

13:55
07/18/18
07/18
13:55
07/18/18
13:55
Conference/Events
House Financial Services Committee to hold a hearing »

The Monetary Policy &…

GLW

Corning

$29.31

0.12 (0.41%)

13:54
07/18/18
07/18
13:54
07/18/18
13:54
Hot Stocks
Corning introduces Gorilla Glass 6, 'most durable cover glass to date' »

Corning introduced its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

TSLA

Tesla

$321.21

-1.58 (-0.49%)

13:50
07/18/18
07/18
13:50
07/18/18
13:50
Periodicals
Germany asks Tesla owners to pay back EUR 4000 incentive, electrek says »

Tesla's ongoing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Aug

13:45
07/18/18
07/18
13:45
07/18/18
13:45
General news
Fed Chairman Powell's 2-day semi-annual testimony has concluded »

Fed Chairman…

13:45
07/18/18
07/18
13:45
07/18/18
13:45
General news
Breaking General news story  »

June Beige Book to be…

GM

General Motors

$39.90

-0.15 (-0.37%)

, FCAU

Fiat Chrysler

$19.37

-0.295 (-1.50%)

13:42
07/18/18
07/18
13:42
07/18/18
13:42
Periodicals
The U.S. auto industry aligned in push back on tariffs, WSJ says »

The U.S. auto complex,…

GM

General Motors

$39.90

-0.15 (-0.37%)

FCAU

Fiat Chrysler

$19.37

-0.295 (-1.50%)

DLPH

Delphi Technologies

$45.78

0.87 (1.94%)

BWA

BorgWarner

$46.47

0.8 (1.75%)

MGA

Magna

$61.62

1.03 (1.70%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 18

    Sep

HPQ

HP Inc.

$23.38

-0.22 (-0.93%)

13:40
07/18/18
07/18
13:40
07/18/18
13:40
Options
Short-term put buying in H-P »

Short-term put buying in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:30
07/18/18
07/18
13:30
07/18/18
13:30
General news
FX Action: USD-CAD »

FX Action: USD-CAD has…

13:25
07/18/18
07/18
13:25
07/18/18
13:25
General news
Treasury Action: yields rebounded from lows »

Treasury Action: yields…

AMGN

Amgen

$193.08

-0.85 (-0.44%)

13:25
07/18/18
07/18
13:25
07/18/18
13:25
Conference/Events
Brookings hosts a conversation with FDA Commisioner Gottlieb »

The USC-Brookings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 08

    Aug

GSK

GlaxoSmithKline

$41.00

-0.145 (-0.35%)

, PFE

Pfizer

$37.63

-0.04 (-0.11%)

13:23
07/18/18
07/18
13:23
07/18/18
13:23
Hot Stocks
GSK's ViiV to share data from landmark 2-drug regimen trials at AIDS 2018 »

ViiV Healthcare, the…

GSK

GlaxoSmithKline

$41.00

-0.145 (-0.35%)

PFE

Pfizer

$37.63

-0.04 (-0.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 22

    Aug

  • 10

    Sep

RHT

Red Hat

$147.95

0.43 (0.29%)

13:20
07/18/18
07/18
13:20
07/18/18
13:20
Options
Notable position opened in RedHat »

Notable position opened…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

13:17
07/18/18
07/18
13:17
07/18/18
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

13:16
07/18/18
07/18
13:16
07/18/18
13:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GGP

GGP

$20.45

-0.25 (-1.21%)

13:15
07/18/18
07/18
13:15
07/18/18
13:15
Options
General Growth put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVS

Novartis

$80.55

1.83 (2.32%)

13:12
07/18/18
07/18
13:12
07/18/18
13:12
Periodicals
Novartis considering range of options for Sandoz generics unit, Bloomberg says »

Novartis is evaluating a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVS

Novartis

$80.56

1.84 (2.34%)

, TEVA

Teva

$23.46

0.32 (1.38%)

13:11
07/18/18
07/18
13:11
07/18/18
13:11
Recommendations
Novartis, Teva, Mylan, Pfizer, Amgen, Eli Lilly analyst commentary  »

Novartis report has…

NVS

Novartis

$80.56

1.84 (2.34%)

TEVA

Teva

$23.46

0.32 (1.38%)

MYL

Mylan

$36.02

-0.35 (-0.96%)

PFE

Pfizer

$37.61

-0.06 (-0.16%)

AMGN

Amgen

$193.01

-0.92 (-0.47%)

LLY

Eli Lilly

$90.07

0.5 (0.56%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 24

    Jul

  • 08

    Aug

  • 22

    Aug

  • 10

    Sep

  • 16

    Sep

  • 13

    Nov

NSANY

Nissan

$0.00

(0.00%)

, TM

Toyota

$132.32

0.82 (0.62%)

13:10
07/18/18
07/18
13:10
07/18/18
13:10
Periodicals
Trump threatens 'retribution' if EU auto-trade deal isn't fair, WSJ says »

U.S. President Donald…

NSANY

Nissan

$0.00

(0.00%)

TM

Toyota

$132.32

0.82 (0.62%)

GM

General Motors

$40.06

0.01 (0.02%)

DDAIF

Daimler AG

$0.00

(0.00%)

HMC

Honda

$29.56

-0.07 (-0.24%)

F

Ford

$10.86

-0.005 (-0.05%)

VLKAY

Volkswagen

$0.00

(0.00%)

FCAU

Fiat Chrysler

$19.37

-0.295 (-1.50%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 15

    Aug

  • 10

    Sep

SIRI

Sirius XM

$7.16

0.08 (1.13%)

13:05
07/18/18
07/18
13:05
07/18/18
13:05
Options
Sirius XM call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 09

    Aug

  • 13

    Aug

  • 14

    Aug

SVU

Supervalu

$21.70

-0.635 (-2.84%)

13:01
07/18/18
07/18
13:01
07/18/18
13:01
Hot Stocks
Blackwells urges Supervalu holders to vote for its six board nominees »

Blackwells Capital, an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:00
07/18/18
07/18
13:00
07/18/18
13:00
General news
Powell acknowledged tariffs could be challenging for monetary policy »

Powell acknowledged…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.